15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Chemours Co, 4 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $15.00 to $25.00, a moderate spread. The average target of $20.13 sits 34% above the current $15.03. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.24 next quarter toward $1.93 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy450%
Hold450%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Chemours Co.
As of Sep, 4 of 8 firms rate CC a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CC EPS & revenue forecast
EPS · NEXT QUARTER
$0.24
Range $0.12 – $0.33 · 8 analysts · +372% YoY
Next period, 8 analysts expect Chemours Co to earn $0.24 a share (range $0.12 – $0.33), versus $0.05 a year earlier. Full-year consensus is $0.99, growing to $1.93 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.4B · 8 analysts · +7% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.4B), +6.9% year-over-year. Full-year consensus is $5.9B, rising to $6.2B next year.
Top analysts covering Chemours Co
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CC.
#1
Joshua Spector
UBS · Rank #40
Hold
$18.00+19.8% to target
Overall win rate
51%
+ Follow
#2
Michael Leithead
Barclays · Rank #49
Hold
$13.00-13.5% to target
Overall win rate
57%
+ Follow
#3
Jeffrey Zekauskas
JP Morgan · Rank #50
Hold
$15.00-0.2% to target
Overall win rate
53%
+ Follow
#4
John McNulty
BMO Capital · Rank #143
Buy
$18.00+19.8% to target
Overall win rate
46%
+ Follow
#5
Arun Viswanathan
RBC Capital · Rank #212
Buy
$22.00+46.4% to target
Overall win rate
33%
+ Follow
CC stock forecast FAQ
What is CC's average 12-month price target?+
The 8 analysts with a live target average $20.13 for Chemours Co over the next 12 months, ranging from a $25.00 high to a $15.00 low.
Is CC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 4 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CC?+
The Street-high target is $25.00 (Mizuho), and the Street-low is $15.00 (JP Morgan). The average of all 8 active targets is $20.13.
How many Wall Street analysts cover CC?+
8 analysts have an active rating on Chemours Co, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering CC?+
Among analysts who currently cover CC, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #40). Their current call is Hold with a $18.00 target.
What is Chemours Co's projected EPS for next quarter?+
The consensus estimate is $0.24 per share (range $0.12 – $0.33) across 8 analysts. Full-year EPS is projected at $0.99, rising to $1.93 the following year.
How much revenue is Chemours Co expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.4B). Full-year revenue is projected at $5.9B, growing to $6.2B next year.
Have analysts been upgrading or downgrading CC lately?+
As of Sep, 4 of 8 firms rate CC a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
